A

Ampersand acquisitions

Ampersand is a private equity firm headquartered in Boston, United States, founded in 1988. Recent Funding has 1 acquisition by Ampersand on record, 1 in the last 12 months; the latest is Purna Pharmaceuticals (Feb 12, 2026). It invests in Biotech, Healthtech, Medical Devices.

Firm profile: Fundraising Fox Open Dataset v2026-09, CC BY 4.0. Portfolio and exit counts are theirs, not Recent Funding's.

What Ampersand is buying

• PPurna PharmaceuticalsFeb 12, 2026Bio and health

Acquired company	Category	Price	Announced
PPurna Pharmaceuticals	Bio and health	Not disclosed publicly	Feb 12, 2026

Acquisitions whose buyer is Ampersand; newest first. A price links to the article that states it. All private equity deals: recent PE acquisitions.

Ampersand take-privates

No take-private by Ampersand is on record yet. See recent take-privates.

What Ampersand buys, by category

Similar private equity firms

• TTPG15 acquisitions · San Francisco
• NNordic Capital7 acquisitions · Stockholm
• AARCHIMED6 acquisitions · France
• AAdvent International6 acquisitions · Boston
• FFrazier Healthcare Partners4 acquisitions · Seattle
• TTA Associates3 acquisitions · Boston
• LLDC3 acquisitions · London
• TTalde Private Equity3 acquisitions · Madrid

Private equity firms that invest in the same sectors (Biotech, Healthtech).

API: /api/v1/pe-firms/ampersand (get a free API key). More: every private equity firm.